The treatment for Scleroderma Associated Myopathy is still largely unknown because there is not enough information about the disease. The Johns Hopkins Rheumatology Division is working to understand more about this kind of Myopathy. In this video, Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of treating this disease.
Johns Hopkins Myositis Center
USE OF THIS SITE
All information contained within the Johns Hopkins Rheumatology website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.